Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Bases de dados
Tipo de estudo
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
Arch Oral Biol ; 28(8): 723-7, 1983.
Artigo em Inglês | MEDLINE | ID: mdl-6314950

RESUMO

The adherence of streptococci to hydroxyapatite spheroids (HAS) depended upon the strain used, the fermentable carbon source available during bacterial growth, the number of times a clinical isolate had been subcultured on laboratory media and the pre-treatment of the HAS. Sucrose greatly stimulated the secondary colonization of Streptococcus mutans strain 3209 on HAS pre-equilibrated with this strain, but no similar effect was observed with glucose. Pre-equilibration of HAS with Streptococcus sanguis 7865 inhibited rather than enhanced subsequent colonization by Strep. mutans strain 3209 in the presence of sucrose.


Assuntos
Streptococcus mutans/fisiologia , Streptococcus sanguis/fisiologia , Sacarose/farmacologia , Adesividade , Placa Dentária/etiologia , Durapatita , Glucose/farmacologia , Humanos , Hidroxiapatitas , Microesferas , Streptococcus mutans/efeitos dos fármacos , Streptococcus sanguis/efeitos dos fármacos
2.
J Antimicrob Chemother ; 11 Suppl: 217-21, 1983 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-6573320

RESUMO

Cefotetan excretion was studied in 17 patients undergoing biliary or pancreatic surgery. The antibiotic was detected in bile taken from the common bile duct within 15 min of a 1 g iv bolus and therapeutic plasma levels were found up to 10 h after administration. Even higher concentrations of cefotetan were measured in the bile from functioning gall bladders, despite the presence of gall stones. Concentrations of cefotetan in bile from the common bile ducts and functioning gall bladders were greater than the plasma concentrations at all times. These concentrations exceed the in-vitro minimum inhibitory concentrations (MIC) for most common biliary tract pathogens.


Assuntos
Antibacterianos/metabolismo , Sistema Biliar/metabolismo , Cefalosporinas/metabolismo , Cefamicinas/metabolismo , Bile/metabolismo , Doenças Biliares/tratamento farmacológico , Cefotetan , Cefamicinas/uso terapêutico , Humanos , Cinética
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA